Document is current

Any future updates will be listed below

Reply to “Matters arising: cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach”

Crossref DOI link: https://doi.org/10.1186/s12885-024-12288-5

Published Online: 2024-07-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark